Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 11/17/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Thomas Schaible?

Thomas F. Schaible

Information Technology As Crnd Senior Engineer, Digital and Analyt

Johnson & Johnson Inc

HQ Phone:  (732) 524-0400

Direct Phone: (484) ***-****direct phone

Email: t***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Johnson & Johnson Inc

One Johnson & Johnson Plz

New Brunswick, New Jersey,08933

United States

Company Description

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,900 employ... more

Find other employees at this company (160,387)

Background Information

Employment History

Clinical Research Scientist

Berlex , Inc.


Vice President of Medical Affairs

Centocor , Inc.


Web References(80 Total References)


Speaker Bio's | the state of clinical development conference - january 10-11, 2012, philadelphia pa | www.stateofclindev.com

www.stateofclindev.com [cached]

Tom Schaible
Vice President of Medical Affairs, Jannsen Bio pharm at Johnson & Johnson


Remicade Lawyers - Remicade Side Effects Attorneys - Rheumatoid Arthritis Treatment - Pharmaceutical Litigation Law Firm

www.personalinjurylawcal.com [cached]

Tom Schaible, vice president of medical affairs at Johnson & Johnson's Centocor unit, said, "We don't really know if these tumors are drug-related or not, but because they occur we report them in our label."


Society : The Society - News from Reuters

www.leukemia-lymphoma.org [cached]

Remicade's label also includes clinical trial data regarding malignancies and says it is insufficient to determine whether the drug is related, said Tom Schaible, Vice President for Medical Affairs for Johnson & Johnson's Centocor unit."The unmet medical need met by Remicade provides a benefit-risk relationship that is clearly in favor of benefit," he added.


www.northernfunds.com

Remicade's label also includes clinical trial data regarding malignancies and says it is insufficient to determine whether the drug is related, said Tom Schaible, vice president for medical affairs for Johnson & Johnson's Centocor unit. "The unmet medical need met by Remicade provides a benefit-risk relationship that is clearly in favor of benefit," he added.


Speakers - Life Sciences Future - It's Here

lifesciencesfuture.com [cached]

Thomas Schaible, Ph.D.
Formerly Vice President, Medical Affairs, Janssen Biotech Bio Thomas F. Schaible, Ph.D. is the Vice President, Medical Affairs, Janssen Biotech, Inc. (JBI), which was formerly Centocor. He leads the scientific and medical commercial support for JBI's marketed products and serves on JBI's Management Board. Since joining Centocor in 1987 in the Clinical Research group, Dr. Schaible has been an important contributor to Centocor's success. He led the teams that gained the approval for the use of Remicade in treating Crohn's disease in 1998 and rheumatoid arthritis in 1999, for which he received the Johnson Medal, the highest award for research innovation at Johnson and Johnson. He then started the Medical Affairs organization and has responsibility for the post-marketing research and educational initiatives that has supported Remicade's growth since its approval. The JBI Medical Affairs organization now supports a portfolio of immunology products (Remicade, Stelara and Simponi), oncology products (Doxil and Zytiga) and a nephrology product (Procrit). His organization is responsible for all phase IIIb/IV clinical trials, observational registries, as well as investigator-initiated trials. The organization also includes a group based in Leiden, The Netherlands that provides post-marketing support to support our strategic partner, Merck, for sales and marketing of Remicade and Simponi in the European territories. Prior to joining Centocor, Tom was an Assistant Professor of Medicine and Physiology at the Albert Einstein College of Medicine in New York where he was the recipient of NIH RO1 grants and an NIH Research Career Development Award. Dr. Schaible holds a Bachelor of Science degree in Biology from Trinity College and a Ph.D. in Physiology from Rutgers University. He did his Postdoctoral Fellowship in Cardiac Physiology and Biochemistry at the Albert Einstein College of Medicine.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory